Thomas J. Bollyky, Chloe Searchinger, and Prashant Yadav |
Amoxicillin penicillin antibiotics are seen in the pharmacy at a free medical and dental health clinic in Los Angeles. (Lucy Nicholson/Reuters) |
The United States no longer manufactures many everyday, essential medicines Americans take, but a blanket tariff—President Donald Trump’s proposed remedy—could worsen the problem. In Foreign Affairs, CFR Senior Fellow, Bloomberg Chair in Global Health, and Global Health Program Director Thomas J. Bollyky, Research Associate Chloe Searchinger, and Senior Fellow Prashant Yadav review the history of U.S. dependence on foreign drugs and explain why certain medicines and their ingredients are no longer made at home or are at risk of being offshored. Reversing those trends, they argue, requires targeting product-specific root causes beyond low labor costs. Read the article
|
|
|
Nearly six months after the Trump administration drastically cut development assistance for health, new data on global health funding reveals a different landscape taking shape. For Think Global Health, Associate Editor Allison Krugman illustrates which multilateral organizations and individual countries have been hardest hit by health funding cuts and how other major donors have been contributing to health programming globally. Explore the article
|
|
|
Luciana L. Borio and Phil Krause |
U.S. Food and Drug Administration (FDA) Commissioner Marty Makary announces the FDA’s intent to phase out petroleum-based synthetic dye use in the nation’s food supply in Washington, DC. (Elizabeth Frantz/Reuters) |
The Food and Drug Administration (FDA) has faced major controversy, budget, and workforce cuts in the first six months of the second Trump administration. In STAT, two former FDA officials—CFR Senior Fellow Luciana L. Borio and former deputy director of FDA’s Office of Vaccines Research and Review Phil Krause—outline a five-step strategy for newly appointed FDA leaders to follow, starting with strengthening the FDA’s scientific review divisions. Read the piece
|
|
|
A person leaves flowers next to a covered-over USAID sign at the agency’s headquarters in Washington. (Nathan Howard/Reuters) |
U.S. soft power—once seen as the “gleaming crown jewel of American influence”—has weakened due to the dismantling of USAID, the sudden withdrawal of U.S. global health efforts, and cuts to federal research funding. In the South China Morning Post, CFR Senior Fellow Yanzhong Huang explores whether China is poised to fill that void and overcome what has traditionally been viewed as a major weakness in its foreign policy and struggle for preeminence. Read the full article
|
|
|
A mother carries her child as she lines up to register for a pneumococcal vaccination at a health center in Managua, Nicaragua. (Oswaldo Rivas/Reuters) |
|
|
Trump’s executive order to lower U.S. drug costs to most-favored-nation reference pricing is limited to high-income countries, writes Yadav in Think Global Health, but it could still diminish affordable access to essential medicines, particularly in low-income health-care systems. Read the op-ed
|
|
|
More on Global Health From CFR |
| |
Think Global Health is a multi-contributor website that examines the ways in which changes in health are reshaping economies, societies, and the everyday lives of people worldwide. |
| |
|
CFR Events on Global Health |
Emerging Threats to Public Health with Bollyky; Kate Wells, public health reporter at Michigan Public; and Carla Anne Robbins, senior fellow at CFR
Empowering Local Science and Innovation to Strengthen Global Health Security and Development with Yadav; John Simon, founding partner of Total Impact Capital, former U.S. ambassador to the African Union, and former executive vice president of the U.S. Overseas Private Investment Corporation; and Peter Singer, professor emeritus of medicine at the University of Toronto, former special advisor to the director general of the World Health Organization, and former CEO of Grand Challenges Canada
The Avian Flu and Its Global Ramifications with Bollyky; Paul Friedrichs, adjunct professor of surgery at Uniformed Services University; Nicole Lurie, executive director of preparedness and response and U.S. director at the Coalition for Epidemic Preparedness Innovations; and Michael T. Osterholm, McKnight presidential endowed chair in public health and director of the Center for Infectious Disease Research and Policy at the University of Minnesota
|
| |
Generic Drugmakers Resist Trump’s Calls for More U.S. Manufacturing (featuring Prashant Yadav, Wall Street Journal)
How to Make America Healthy: The Real Problems—and Best Fixes (featuring Thomas J. Bollyky, Nature)
Chinese Students Are Frustrated With U.S. Visa Bans: “What Now?” (featuring Yanzhong Huang, New York Times)
White House Proposal Would Slash Global Health Spending (featuring Thomas J. Bollyky, CNN)
Will New Tariffs Make the Cost of Healthcare Go Up? (featuring Prashant Yadav, WWL First News With Tommy Tucker)
More Than 200 Children Found With High Lead Levels (featuring Yanzhong Huang, CNN)
Joseph Nye, Founder of the Theory of “Soft Power,” Has Passed Away. He Once Said That “Trump Does Not Understand Soft Power” (featuring Yanzhong Huang, Sina)
The Trade War’s Pharma Carve-Out (featuring Yanzhong Huang, Wire China) |
| |
|
